Company: SXTPW
Filing Date: 2025-07-16
Form Type: 424B4
Source: 0001213900-25-064472
Chunk: 42

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-16
Form: 424B4
Chunk 42
---
 upon exercise of the Warrants at the time that holders wish to exercise such
Warrants, they will only be able to exercise them on a “cashless basis” provided that an exemption from registration is available.
As a result, the number of shares of common stock that holders will receive upon exercise of the Warrants will be fewer than it would
have been had such holder exercised his, her or its Warrants for cash. Further, if an exemption from registration is not available, holders
would not be able to exercise on a cashless basis and would only be able to exercise their Warrants for cash if a current and effective
registration statement relating to the common stock issuable upon exercise of the Warrants is available. If we are unable to maintain
a current and effective registration statement relating to the common stock issuable upon exercise of the Warrants, the potential “upside”
of the holder’s investment in us may be reduced or the Warrants may expire worthless.

The Warrants may have an adverse effect on the market price of our common stock and make it more difficult to effect a business combination.

We will be issuing the Warrants to purchase shares
of common stock as part of this offering. To the extent we issue shares of common stock to effect a future business combination, the potential
for the issuance of a substantial number of additional shares upon exercise of the Warrants, or the potential for us to be required to
pay to the Warrant holders an amount in cash equal to the Black-Scholes Value (as defined in the Warrants), could make us a less attractive
acquisition vehicle in the eyes of a target business. Such Warrants, when exercised, will increase the number of issued and outstanding
shares of common stock and reduce the value of the shares issued to complete the business combination. Accordingly, the Warrants may make
it more difficult to effectuate a business combination or increase the cost of acquiring a target business. Additionally, the sale, or
even the possibility of a sale, of the shares of common stock underlying the Warrants could have an adverse effect on the market price
for our securities or on our ability to obtain future financing. If and to the extent the Warrants are exercised, you may experience dilution
to your holdings.

We will not receive any meaningful amount of additional funds upon the exercise of the Pre-Funded Warrants.

Each Pre-Funded Warrant will be exercisable by
means of payment of the nominal cash purchase price upon exercise. Accordingly, we will